Comparison of Computertomography Scan, Electrical Impedance Tomography, and Ultrasound of the Lung in Infants
Launched by MEDICAL UNIVERSITY OF VIENNA · Aug 3, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different ways to examine the lungs of infants who are hospitalized. Researchers want to compare three imaging techniques: a CT scan (which uses X-rays to create detailed pictures), Electrical Impedance Tomography (EIT, which measures how well electricity moves through lung tissue), and Ultrasound (which uses sound waves to create images). The goal is to understand how these methods can help doctors tell the difference between parts of the lung that are collapsed and those that are over-inflated, which is important for treating lung injuries in infants.
To be eligible for this study, infants must be under 12 months old and scheduled to have a CT scan at the Medical University of Vienna's Pediatrics Department. Unfortunately, infants with unstable heart, lung, or brain issues, recent chest surgery, or skin wounds on their chest won't be able to participate. If a baby qualifies, they can expect to have their lung function assessed using these different imaging techniques, which could lead to better care in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients hospitalized at the Department of Pediatrics of the Medical University of Vienna who will get a CT scan of the thorax.
- • Patients aged up to 12 months
- Exclusion Criteria:
- • Unstable cardiovascular, respiratory and/or neurological conditions.
- • Sternotomy during the previous 15 days.
- • Thoracic skin lesions or wounds (including burns) on the thorax, where the EIT-electrode-belt would be placed.
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Tobias Werther, MD, PhD
Principal Investigator
Medical University of Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials